(Q46447759)

22 December 2017

title

Epidermal growth factor promotes proliferation and improves restoration after intestinal ischemia-reperfusion injury in rats (English)

1 reference

22 December 2017

1 reference

Yanxia Geng

1

1 reference

22 December 2017

Jieshou Li

2

1 reference

22 December 2017

Fan Wang

3

1 reference

22 December 2017

Qiurong Li

4

1 reference

22 December 2017

Xing Wang

5

1 reference

22 December 2017

Liqun Sun

6

1 reference

22 December 2017

Weiqin Li

7

1 reference

22 December 2017

publication date

1 June 2013

1 reference

22 December 2017

published in

Inflammation

1 reference

22 December 2017

volume

36

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

670-679

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s10753-012-9591-x

exact match

0 references

cites work

Can we protect the gut in critical illness? The role of growth factors and other novel approaches

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9591-X

21 January 2018

Epidermal Growth Factor

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9591-X

Epidermal growth factor reduces ischemia-reperfusion injury in rat small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9591-X

Prophylactic use of epidermal growth factor reduces ischemia/reperfusion intestinal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9591-X

IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9591-X

Different changes in the expression of multiple kinds of tight-junction proteins during ischemia-reperfusion injury of the rat ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9591-X

Occludin: structure, function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9591-X

The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9591-X

Intravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9591-X

The role of growth factors in gastrointestinal cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9591-X

Epidermal growth factor stimulates the restitution of rat gastric mucosa in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9591-X

Enterocyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9591-X

Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9591-X

A pilot study of the use of epidermal growth factor in pediatric short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9591-X

Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9591-X

Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9591-X

Ileal cytokine dysregulation in experimental necrotizing enterocolitis is reduced by epidermal growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9591-X

Epidermal growth factor in clinical practice - a review of its biological actions, clinical indications and safety implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-012-9591-X

A multicenter, randomized, double-blind clinical trial examining the effect of oral human recombinant epidermal growth factor on the healing of duodenal ulcers

21 January 2018

1 reference

12 December 2020

Serum D(-)-lactate levels as an aid to diagnosing acute intestinal ischemia

1 reference

12 December 2020

Intestinal cytokine response after gut ischemia: role of gut barrier failure

1 reference

12 December 2020

Trophic action of epidermal growth factor on the pancreas and gastroduodenal mucosa in rats

1 reference

12 December 2020

Effects of intraluminal epidermal growth factor on mucosal proliferation in the small intestine of adult rats

1 reference

12 December 2020

Amiloride moderates increased gut permeability and diminishes mesenteric lymph-mediated priming of neutrophils in trauma/hemorrhagic shock

1 reference

12 December 2020

Epidermal growth factor receptor of the intestinal enterocyte. Localization to laterobasal but not brush border membrane.

1 reference

12 December 2020

Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal

1 reference

12 December 2020

Intestinal mucosa remodeling by recombinant human epidermal growth factor(1-48) in neonates with severe necrotizing enterocolitis

1 reference

12 December 2020

Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock

1 reference

12 December 2020

Relationship between plasma D(-)-lactate and intestinal damage after severe injuries in rats.

1 reference

12 December 2020

10.1007/S10753-012-9591-X

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017